TECX Company Profile and Key Details

TECX has shown sold momentum, gaining 8.35% over the past week and 35.68% over the past quarter, though year-to-date performance is down -53.63%. Short-term trend indicators are mixed aligned (SMA20 7.64%, SMA50 14.13%, SMA200 7.42%). The stock’s 14-day RSI is 60.22 (firm momentum), while the ATR of 1.53 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -64.94% below its high and over 56.28% above its low. Average 10-day trading volume of 328.69 thousand shares is below the 3-month average of 472.58 thousand, indicating normal recent market interest.

Tectonic Therapeutic, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $9.34. This means the shares are trading above this model’s fair value.

Tectonic Therapeutic, Inc. has 18.71 million shares outstanding. The public float is 9.74 million shares, elevated short interest at 23.63% of float. This equals 2.51 million shares. The short ratio is 11.06 days. Institutional investors hold 105.25% of the float. Insiders own 38.21%. SPRINGER TIMOTHY A holds 1.50 million shares, MCGUIRE TERRANCE has 573.06 thousand shares and Lochner Daniel has 4.62 thousand shares.

Tectonic Therapeutic, Inc. generated EPS of -$3.85 over the past year. Five-year average earnings growth is 26.54%. Wall Street analysts project EPS growth of 7.4% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $112.00 to $64.00. The high target offers 423.12% upside. The low target suggests 198.93% downside. The mean target is $89.25. This offers 316.86% upside. Tectonic Therapeutic, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by -2.86%. The prior quarter beat by 9.18%. Over the last six quarters, Apple has recorded several small beats. These include 94.39% in August 14, 2024.

Tectonic Therapeutic, Inc. (NASDAQ:TECX) shares are down -53.63% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Tectonic Therapeutic, Inc. trading at a premium to the broader market with a P/E of -5.91. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $74.38, suggesting 247.41% upside. Our AI forecast model points to short-term weakness (-6.77% over two weeks), a medium-term rise (17.61% over three months), and a longer-term gain (22.23% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Tectonic Therapeutic, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.77%, with price expected at $19.96 by January 05, 2026, within a range of $18.83 to $20.94 3-Month Outlook: Projected rise of 17.61%, reaching $25.18 by March 20, 2026, with a range of $20.60 to $27.92. 1-Year Outlook: Projected gain of 22.23%, with price at $26.17 by December 22, 2026, within a range of $22.60 to $29.36.

Tectonic Therapeutic, Inc. trades at a P/E ratio of -5.91, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 1.49 suggesting the stock is closer to book value. The P/FCF stands at -6.35, also above market averages.